MYX — Mycelx Technologies Share Price
Last trade - 00:00- £12.41m
- £11.29m
- $10.03m
- 43
- 31
- 70
- 43
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 22.76 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.65 | ||
| Price to Tang. Book | 1.8 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.3 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.68% | ||
| Return on Equity | -24.64% | ||
| Operating Margin | -18.38% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 26.95 | 11.91 | 7.1 | 8.48 | 10.03 | 9.36 | 12.31 | -6.12% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MYCELX Technologies Corporation is a clean water and clean air technology company. The Company provides clean water technology equipment and related services to the oil and gas, power, marine and heavy manufacturing sectors. MYCELX systems provide removal of hydrocarbons, PFAS, and other difficult contaminants from water and air over conventional treatment systems. Its technology, MYCELX Polymer, permanently removes oil from water upon contact, preventing the reentry of oil into the water stream. The MYCELX Polymer uses molecular cohesion to instantly remove oil from water, reaching critically low levels for discharge or reuse. MYCELX products permanently bind with hydrocarbons and remove free and emulsified oils and associated hydrocarbons. The MYCELX Polymer is integrated into engineered substrates for diverse uses in multiple industries. Its systems remove crude oils, condensate (from gas production), tar, waxes, asphaltenes, gasoline range and diesel range hydrocarbons, and others.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- March 24th, 1994
- Public Since
- August 4th, 2011
- No. of Employees
- 18
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- London Stock Exchange
- Shares in Issue
- 22,983,023
- Address
- 1650 International Court, Suite 100, NORCROSS, 30093
- Web
- https://www.mycelx.com
- Phone
- +1 7705343118
- Auditors
- Deloitte & Touche LLP
Latest News for MYX
Upcoming Events for MYX
Full Year 2023 Mycelx Technologies Corp Earnings Release
Similar to MYX
ADVFN
London Stock Exchange
Alpha Financial Markets Consulting
London Stock Exchange
Andrews Sykes
London Stock Exchange
Anexo
London Stock Exchange
Ashtead
London Stock Exchange
FAQ
As of Today at 19:14 UTC, shares in Mycelx Technologies are trading at 54.00p. This share price information is delayed by 15 minutes.
Shares in Mycelx Technologies last closed at 54.00p and the price had moved by +71.43% over the past 365 days. In terms of relative price strength the Mycelx Technologies share price has outperformed the FTSE All Share Index by +68.47% over the past year.
The overall consensus recommendation for Mycelx Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Mycelx Technologies does not currently pay a dividend.
Mycelx Technologies does not currently pay a dividend.
Mycelx Technologies does not currently pay a dividend.
To buy shares in Mycelx Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 54.00p, shares in Mycelx Technologies had a market capitalisation of £12.41m.
Here are the trading details for Mycelx Technologies:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MYX
Based on an overall assessment of its quality, value and momentum Mycelx Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Mycelx Technologies is 95.00p. That is 75.93% above the last closing price of 54.00p.
Analysts covering Mycelx Technologies currently have a consensus Earnings Per Share (EPS) forecast of -$0.12 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mycelx Technologies. Over the past six months, its share price has underperformed the FTSE All Share Index by -22.74%.
As of the last closing price of 54.00p, shares in Mycelx Technologies were trading +2.18% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mycelx Technologies PE ratio based on its reported earnings over the past 12 months is 22.76. The shares last closed at 54.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Mycelx Technologies' management team is headed by:
- Thomas Lamb - NEC
- Haluk Alper - PRE
- Connie Mixon - CEO
- Kimberly Slayton - CFO
- Andre Schnabl - NID